Leading adaptive, productive multi-arm phase 2 clinical trial for glioblastoma is research team.

Published Date: 20 Sep 2023

Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers across the nation, has reported on an innovative phase 2 clinical trial that aims to identify new potential treatments for glioblastoma.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

3.

Taking vitamin D daily decreased cancer mortality, according to a study.

4.

Study reveals increase in late-stage breast cancer diagnoses in US

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot